查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1676247

全球组织诊断市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Tissue Diagnostics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格

全球组织诊断市场规模预计将从 2024 年的 66.4 亿美元成长到 2033 年的 144.8 亿美元，在 2026 年至 2033 年的预测期内呈现 9.04% 的强劲年复合成长率(CAGR)。

受癌症发病率不断上升以及对准确及时的诊断解决方案的需求不断增长的推动，组织诊断市场有望实现大幅增长。随着医疗保健提供者寻求透过早期检测和个人化治疗计划来改善患者的治疗效果，对先进的组织诊断技术的需求正在激增。组织病理学、免疫组织化学和分子诊断方面的创新正在提高组织分析的准确性和效率，使医疗保健专业人员能够就患者护理做出明智的决定。数位病理学与人工智慧的融合正在进一步改变这一格局，使得实验室的影像分析更加精确，工作流程也得到改善。

此外，对个人化医疗的日益重视正在影响组织诊断市场。随着对癌症生物学理解的不断进步，对于能够识别与不同癌症类型相关的特定生物标记的诊断测试的需求日益增加。这一趋势正在推动伴随诊断的发展，以指导治疗决策并改善治疗结果。此外，对肿瘤学研究和开发的日益重视也促进了组织诊断的创新，从而引入了增强诊断能力的新型检测方法和技术。

此外，旨在改善癌症筛检和诊断的宣传活动和措施的兴起也促进了组织诊断市场的成长。随着患者越来越意识到早期检测的重要性，对可靠且可获得的诊断解决方案的需求预计会增加。学术机构、研究组织和产业参与者之间的合作也推动了组织诊断的进步，确保新技术满足医疗保健提供者和患者不断变化的需求。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：组织诊断产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按产品进行市场吸引力分析
    • 依技术进行市场吸引力分析
    • 依疾病类型分析市场吸引力
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球组织诊断市场分析：按产品

  • 产品概览
  • 按产品进行的历史和预测数据分析
  • 耗材（抗体、试剂盒、试剂、探针）
  • 仪器（载玻片染色系统、扫描器、组织处理系统、其他仪器（自动盖玻片机、切片机、嵌入系统、石蜡分配器和载玻片贴标机））

第 6 章：全球组织诊断市场分析：按技术

  • 技术概览
  • 按技术进行的历史和预测数据分析
  • 免疫组织化学
  • 原位杂交
  • 数位病理学和工作流程管理
  • 特殊染色

第 7 章：全球组织诊断市场分析：按疾病类型

  • 疾病类型概览
  • 按疾病类型进行的历史和预测数据分析
  • 乳癌
  • 胃癌
  • 淋巴瘤
  • 摄护腺癌
  • 非小细胞肺癌
  • 其他疾病类型（神经疾病、心血管疾病、免疫疾病、传染病、骨癌、结肠癌、甲状腺癌、子宫颈癌、皮肤癌、胆囊癌、B型肝炎、爱泼斯坦-巴尔病毒、肝炎、肌肉营养不良症、肾细胞癌和多形性肉瘤。）

第 8 章：全球组织诊断市场分析：按最终用户

  • 最终用户概览
  • 最终用户的历史和预测数据分析
  • 医院
  • 研究实验室
  • 製药公司
  • 合约研究组织 (CRO)
  • 其他最终用户（参考实验室和学术研究实验室）

第 9 章：全球组织诊断市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 10 章：组织诊断公司的竞争格局

  • 组织诊断市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PHC Holdings Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abbott Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GE Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cell Signaling Technology Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioGenex
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Siemens
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11211672

Global Tissue Diagnostics Market size is anticipated to grow from USD 6.64 Billion in 2024 to USD 14.48 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.04% during the forecast period of 2026 to 2033.

The tissue diagnostics market is poised for significant growth, driven by the increasing prevalence of cancer and the rising demand for accurate and timely diagnostic solutions. As healthcare providers seek to improve patient outcomes through early detection and personalized treatment plans, the need for advanced tissue diagnostic technologies is surging. Innovations in histopathology, immunohistochemistry, and molecular diagnostics are enhancing the accuracy and efficiency of tissue analysis, enabling healthcare professionals to make informed decisions regarding patient care. The integration of digital pathology and artificial intelligence is further transforming the landscape, allowing for more precise image analysis and improved workflow in laboratories.

Moreover, the growing emphasis on personalized medicine is influencing the tissue diagnostics market. As the understanding of cancer biology advances, there is a rising demand for diagnostic tests that can identify specific biomarkers associated with different cancer types. This trend is driving the development of companion diagnostics that guide treatment decisions and improve therapeutic outcomes. Additionally, the increasing focus on research and development in oncology is fostering innovation in tissue diagnostics, leading to the introduction of novel assays and technologies that enhance diagnostic capabilities.

Furthermore, the rise of awareness campaigns and initiatives aimed at improving cancer screening and diagnosis is contributing to the growth of the tissue diagnostics market. As patients become more informed about the importance of early detection, the demand for reliable and accessible diagnostic solutions is expected to rise. Collaborations between academic institutions, research organizations, and industry players are also driving advancements in tissue diagnostics, ensuring that new technologies meet the evolving needs of healthcare providers and patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
  • Instruments
  • Slide-staining Systems
  • Scanners
  • Tissue-processing Systems
  • Other Instruments (automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers)

By Technology

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology & Workflow Management
  • Special Staining

By Disease Type

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Other Disease Types (neurological disease, cardiovascular disease, immunological diseases, infectious diseases, cancers of the bone, colon, thyroid, cervix, and skin; gallbladder carcinoma; HBV; Epstein-Barr virus; hepatitis; muscular dystrophy; renal cell carcinoma; and pleomorphic sarcomas.)

By End User

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Other End Users (reference laboratories and academic research laboratories)
  • COMPANIES PROFILED
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • PHC Holdings Corporation
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. TISSUE DIAGNOSTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Disease Type
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Consumables (Antibodies, Kits, Reagents, Probes) Historic and Forecast Sales By Regions
  • 5.4. Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Historic and Forecast Sales By Regions

6. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Immunohistochemistry Historic and Forecast Sales By Regions
  • 6.4. In Situ Hybridization Historic and Forecast Sales By Regions
  • 6.5. Digital Pathology & Workflow Management Historic and Forecast Sales By Regions
  • 6.6. Special Staining Historic and Forecast Sales By Regions

7. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY DISEASE TYPE

  • 7.1. Overview By Disease Type
  • 7.2. Historical and Forecast Data Analysis By Disease Type
  • 7.3. Breast Cancer Historic and Forecast Sales By Regions
  • 7.4. Gastric Cancer Historic and Forecast Sales By Regions
  • 7.5. Lymphoma Historic and Forecast Sales By Regions
  • 7.6. Prostate Cancer Historic and Forecast Sales By Regions
  • 7.7. Non-small Cell Lung Cancer Historic and Forecast Sales By Regions
  • 7.8. Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Historic and Forecast Sales By Regions

8. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Research Laboratories Historic and Forecast Sales By Regions
  • 8.5. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
  • 8.7. Other End Users (Reference Laboratories And Academic Research Laboratories) Historic and Forecast Sales By Regions

9. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE TISSUE DIAGNOSTICS COMPANIES

  • 10.1. Tissue Diagnostics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF TISSUE DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. F. Hoffmann-La Roche Ltd
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Danaher Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. PHC Holdings Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Agilent Technologies Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Thermo Fisher Scientific Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Abbott Laboratories
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. GE Healthcare
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Cell Signaling Technology Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BioGenex
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Siemens
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Consumables (Antibodies, Kits, Reagents, Probes) Market Sales By Geography (USD MN)
  • Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Immunohistochemistry Market Sales By Geography (USD MN)
  • In Situ Hybridization Market Sales By Geography (USD MN)
  • Digital Pathology & Workflow Management Market Sales By Geography (USD MN)
  • Special Staining Market Sales By Geography (USD MN)
  • Analysis By Disease Type (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Gastric Cancer Market Sales By Geography (USD MN)
  • Lymphoma Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
  • Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Other End Users (Reference Laboratories And Academic Research Laboratories) Market Sales By Geography (USD MN)
  • Global Tissue Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Tissue Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Tissue Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Consumables (Antibodies, Kits, Reagents, Probes) Market Sales By Geography (USD MN)
  • Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Immunohistochemistry Market Sales By Geography (USD MN)
  • In Situ Hybridization Market Sales By Geography (USD MN)
  • Digital Pathology & Workflow Management Market Sales By Geography (USD MN)
  • Special Staining Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Type (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Gastric Cancer Market Sales By Geography (USD MN)
  • Lymphoma Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
  • Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Other End Users (Reference Laboratories And Academic Research Laboratories) Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.